Widely used:Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$45 Mln
Revenue (TTM)
$0 Mln
Net Profit (TTM)
$0 Mln
ROE
-39.6 %
ROCE
-- %
P/E Ratio
--
P/B Ratio
21.1
Industry P/E
22.44
EV/EBITDA
-3
Div. Yield
0 %
Debt to Equity
-0.1
Book Value
$--
EPS
$-5
Face value
--
Shares outstanding
3,813,520
CFO
$-42.83 Mln
EBITDA
$-66.33 Mln
Net Profit
$-86.08 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Zivo Bioscience (ZIVO)
| -33.9 | -21.0 | -20.6 | 78.0 | -11.0 | -23.1 | -15.1 |
|
BSE Sensex*
| 4.0 | -1.2 | 9.7 | 5.7 | 16.6 | 19.4 | 11.7 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
|---|---|---|---|---|---|---|---|
|
Zivo Bioscience (ZIVO)
| 1,650.0 | -92.0 | -12.9 | 1,813.3 | -9.1 | 26.9 | 37.2 |
|
S&P Small-Cap 600
| 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 | -9.7 |
|
BSE Sensex
| 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 | 5.9 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Zivo Bioscience (ZIVO)
|
14.2 | 45.1 | 0.1 | -16.3 | -3,138.4 | -- | -- | 21.1 |
| 159.3 | 5,268.7 | 964.5 | 136.5 | 19.9 | 11.4 | 38.7 | 4.3 | |
| 62.7 | 7,979.2 | 2,192.1 | 281.0 | 14.7 | -- | 29.4 | 0.0 | |
| 38.6 | 5,695.3 | 5,502.5 | 171.6 | 2.8 | 3.8 | 33.7 | 1.4 | |
| 15.9 | 3,382.4 | 5,080.9 | 228.1 | 6.9 | 16.2 | 14.8 | 2.4 | |
| 71.9 | 3,622.7 | 1,014.6 | 15.6 | 2.1 | 1.5 | 247.6 | 3.4 | |
| 137.5 | 8,891.6 | 7,361.0 | 628.0 | 14.0 | 15.5 | 14.6 | 2.2 | |
| 167.8 | 4,615.1 | 1,886.5 | 169.7 | 12.0 | 17.5 | 27.3 | 4.6 | |
| 45.9 | 10,940.9 | 17,979.4 | 1,208.1 | 9.7 | 32.9 | 9.1 | 3.5 | |
| 112.5 | 6,330.7 | 7,884.6 | 357.3 | 10.0 | 9 | 19.9 | 1.7 |
ZIVO Bioscience, Inc., together with its subsidiaries, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. The company... operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health. It offers poultry gut health, avian influenza, bovine mastitis, canine joint health, human immune modification, human functional food ingredients, algal biomass for human food, and biomass for supporting skin health and anti-aging. The company was formerly known as Health Enhancement Products, Inc. and changed its name to ZIVO Bioscience, Inc. in October 2014. ZIVO Bioscience, Inc. is headquartered in Troy, Michigan. Address: 2125 Butterfield Drive, Troy, MI, United States, 48084 Read more
President, CEO & Chairman of the Board
Mr. John B. Payne
President, CEO & Chairman of the Board
Mr. John B. Payne
Headquarters
Troy, MI
Website
Our rating system has guided millions of investors in the past 20 years.
The total asset value of Zivo Bioscience Inc (ZIVO) stood at $ 4 Mln as on 31-Mar-25
The share price of Zivo Bioscience Inc (ZIVO) is $14.22 (NASDAQ) as of 17-Jun-2025 09:57 EDT. Zivo Bioscience Inc (ZIVO) has given a return of -10.98% in the last 3 years.
Zivo Bioscience Inc (ZIVO) has a market capitalisation of $ 45 Mln as on 17-Jun-2025. As per Value Research classification, it is a Small Cap company.
The P/B ratio of Zivo Bioscience Inc (ZIVO) is 21.13 times as on 17-Jun-2025, a 892% premium to its peers’ median range of 2.13 times.
Since, TTM earnings of Zivo Bioscience Inc (ZIVO) is negative, P/E ratio is not available.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Zivo Bioscience Inc (ZIVO) and enter the required number of quantities and click on buy to purchase the shares of Zivo Bioscience Inc (ZIVO).
ZIVO Bioscience, Inc., together with its subsidiaries, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. The company operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health. It offers poultry gut health, avian influenza, bovine mastitis, canine joint health, human immune modification, human functional food ingredients, algal biomass for human food, and biomass for supporting skin health and anti-aging. The company was formerly known as Health Enhancement Products, Inc. and changed its name to ZIVO Bioscience, Inc. in October 2014. ZIVO Bioscience, Inc. is headquartered in Troy, Michigan. Address: 2125 Butterfield Drive, Troy, MI, United States, 48084
The CEO & director of Mr. John B. Payne. is Zivo Bioscience Inc (ZIVO), and CFO & Sr. VP is Mr. John B. Payne.
There is no promoter pledging in Zivo Bioscience Inc (ZIVO).
Some of the close peers are:
| Company | Market Cap($ Mln) |
|---|---|
|
1,070
|
|
|
889
|
|
|
759
|
|
|
625
|
|
|
538
|
|
|
498
|
|
|
464
|
|
|
375
|
|
|
345
|
| Zivo Bioscience Inc. (ZIVO) | Ratios |
|---|---|
|
Return on equity(%)
|
--
|
|
Operating margin(%)
|
-3138.42
|
|
Net Margin(%)
|
-13430.07
|
|
Dividend yield(%)
|
--
|
No, TTM profit after tax of Zivo Bioscience Inc (ZIVO) was $0 Mln.
$3.22
(
